Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$4,613,271
+1.8%
456,7640.0%0.15%
+33.9%
Q3 2022$4,533,000
+12.8%
456,764
+12.5%
0.11%
+18.5%
Q2 2022$4,018,000
+0.4%
405,9000.0%0.09%
+1.1%
Q1 2022$4,002,000
+0.2%
405,9000.0%0.09%
-13.3%
Q4 2021$3,994,000
+1.0%
405,9000.0%0.10%
-8.7%
Q3 2021$3,953,000
+0.7%
405,9000.0%0.12%
-6.5%
Q2 2021$3,925,000405,9000.12%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders